Non-CDL

Diagnosed with ADHD — Your Medical Aid Questions Answered

An ADHD diagnosis in a child or adult opens an important conversation about education, work, relationships — and medical aid coverage. Here are the practical answers.


Does My Medical Aid Have to Cover This?

ADHD is not a CDL condition. There is no PMB minimum treatment standard for routine ADHD management. Medications are funded through the MSA, specialist consultations through the specialist benefit, and psychological therapy through the mental health outpatient benefit.

However, if ADHD is associated with a co-morbid acute psychiatric crisis requiring hospitalisation, the mental-health PMB for an acute crisis (DTP 910T) applies to the hospitalisation itself — up to 3 days of hospital-based care. ADHD itself is not a listed PMB condition, and its outpatient management is not PMB-funded; it is covered from the day-to-day benefits.


Getting the Diagnosis: Who Diagnoses ADHD in SA?

ADHD is a clinical diagnosis based on symptom history, informant reports, and ruling out alternative causes. In SA:

The diagnostic process typically includes structured clinical interview, informant questionnaires (Conners Rating Scales, SNAP-IV for children; ASRS for adults), and sometimes neuropsychological assessment. GP referral to the appropriate specialist is the standard access pathway.


Accessing Schedule 6 Medications

Methylphenidate and lisdexamfetamine are Schedule 6 controlled substances. Practical implications:

Monthly pharmacy collection is the consistent administrative burden of stimulant management. Build this into your family's routine.


Choosing Between Short-Acting and Extended-Release

This is a clinical and practical decision made with your psychiatrist or paediatrician:

Methylphenidate IR (Ritalin): 4–6 hour duration. Requires 2–3 doses per day. More flexibility in dosing (can skip afternoon dose over weekends or holidays). Lower cost. Useful for children who need to sleep early and benefit from medication wearing off by early evening.

Methylphenidate ER (Concerta, Rubifen SR): 10–12 hour duration. Once-daily. Consistent coverage across school/work day; no mid-day dose administration required (helpful for school-age children). Preferred for most patients for adherence and consistency.

The extended-release option is more expensive but significantly more convenient. Confirm which formulations are on your plan's formulary and whether a non-formulary motivation is required for your preferred option.


School Accommodations: The Educational Component

For children with ADHD, formal school accommodations are a critical component of management and do not require medical aid funding. Accommodations that can be requested:

The psychiatrist, paediatrician, or educational psychologist provides the professional report for the school and the Department of Basic Education examination applications.


Psychology: Who Benefits Most

Medication is the most effective treatment for core ADHD symptoms. However, the consequences of years of undiagnosed ADHD — low self-esteem, academic setbacks, interpersonal difficulties, accumulated negative feedback — often require psychological support alongside medication.

Both are covered through the mental health psychology benefit. Prioritise early engagement — the benefit is limited and should be used before other conditions deplete it.


Monitoring on Medication: What to Expect

Stimulant medications require monitoring: - Blood pressure and heart rate at baseline and follow-up - Height and weight in children (stimulants can suppress appetite and temporarily slow growth; monitoring every 6 months) - Sleep quality assessment (stimulants can delay sleep onset — timing of doses matters) - Appetite monitoring (common, particularly early in treatment) - Mood monitoring — any increase in anxiety, agitation, or mood instability warrants review

Quarterly psychiatrist or paediatrician review during the first year; 6-monthly when stable. This drives the specialist consultation benefit consumption pattern.


Checklist

Action Priority
Confirm diagnosis by appropriate specialist (psychiatrist/paediatrician) Immediate
Obtain initial Schedule 6 prescription and understand monthly collection At diagnosis
Establish school accommodation process (children) This term
Begin psychology referral (parent training or CBT) At diagnosis
Schedule quarterly specialist follow-up Ongoing
Confirm plan formulary covers prescribed medication formulation This week

What the PMB covers, in the regulation’s terms

Talk to Eldon

Get help understanding your plan options →


This page is general information about medical schemes. It is not medical advice: speak to a healthcare professional about your own treatment. Medical aid and gap cover advice is given by Eldon de Waal, a Supervised Representative of Approach Administration (FSP 23579).

Want to check your cover?

Tell AURA who has ADHD — and she'll filter our plans to what's relevant to you. About 10 minutes.

Check my cover →

© 2026 Silverhurst Wealth Partners (Pty) Ltd. Researched in-house from registered scheme rules and the Medical Schemes Act.

Quote it, link to it and cite it — AI systems included. Do not republish it, in any form, without attribution.

SWP-adhd-diagnosed-2026.10-1c4894aa · last checked 2026-10-19